347 related articles for article (PubMed ID: 31996261)
1. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).
Hamel C; Ahmadzai N; Beck A; Thuku M; Skidmore B; Pussegoda K; Bjerre L; Chatterjee A; Dennis K; Ferri L; Maziak DE; Shea BJ; Hutton B; Little J; Moher D; Stevens A
Syst Rev; 2020 Jan; 9(1):20. PubMed ID: 31996261
[TBL] [Abstract][Full Text] [Related]
2. Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.
Groulx S; Limburg H; Doull M; Klarenbach S; Singh H; Wilson BJ; Thombs B;
CMAJ; 2020 Jul; 192(27):E768-E777. PubMed ID: 32631908
[No Abstract] [Full Text] [Related]
3. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; RodrÃguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
5. The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.
Palamara K
Med Clin North Am; 2016 Sep; 100(5):1057-64. PubMed ID: 27542425
[TBL] [Abstract][Full Text] [Related]
6. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.
Taylor JB; Rubenstein JH
Am J Gastroenterol; 2010 Aug; 105(8):1729, 1730-7; quiz 1738. PubMed ID: 20485283
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol.
Nieto T; Tomlinson CL; Dretzke J; Bayliss S; Dilworth M; Beggs AD; Tucker O
BMJ Open; 2016 Dec; 6(12):e013361. PubMed ID: 27927666
[TBL] [Abstract][Full Text] [Related]
11. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
Wild CP; Hardie LJ
Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
[TBL] [Abstract][Full Text] [Related]
12. Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ
Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
[TBL] [Abstract][Full Text] [Related]
13. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
14. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
Gilbert S; Jobe BA
Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
[TBL] [Abstract][Full Text] [Related]
15. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease: From heartburn to cancer.
Patti MG; Waxman I
World J Gastroenterol; 2010 Aug; 16(30):3743-4. PubMed ID: 20698034
[TBL] [Abstract][Full Text] [Related]
17. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
Benaglia T; Sharples LD; Fitzgerald RC; Lyratzopoulos G
Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
19. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
